Boston Scientific expects Farapulse approval in 2024
Boston Scientific announced that it initiated the AVANT GUARD clinical trial to evaluate its Farapulse pulsed-field ablation (PFA) system.
Source: massdevice.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Brad Sutton. Real-time updates on events, politics, business and more.